Antibodies,
Journal Year:
2024,
Volume and Issue:
13(2), P. 41 - 41
Published: May 11, 2024
SARS-CoV-2
vaccines
have
contributed
to
attenuating
the
burden
of
COVID-19
pandemic
by
promoting
development
effective
immune
responses,
thus
reducing
spread
and
severity
pandemic.
A
clinical
trial
with
Sputnik-V
vaccine
was
conducted
in
Venezuela
from
December
2020
July
2021.
The
aim
this
study
explore
antibody
reactivity
vaccinated
individuals
towards
different
regions
spike
protein
(S).
Neutralizing
(NAb)
activity
assessed
using
a
commercial
surrogate
assay,
detecting
NAbs
against
receptor-binding
domain
(RBD),
plaque
reduction
neutralization
test.
NAb
levels
were
correlated
antibodies
over
time.
presence
Abs
nucleoprotein
also
determined
rule
out
effect
exposure
virus
during
serological
response.
high
observed
S
specifically
S1
RBD.
S2,
although
recognized
lower
intensity
individuals,
subunit
exhibiting
highest
cross-reactivity
prepandemic
sera.
This
is
agreement
efficacy
reported
for
Sputnik
V
shows
that
able
induce
an
immunity
lasting
at
least
180
days.
dissection
Ab
allowed
us
identify
relevance
epitopes
outside
RBD
are
NAbs.
research
may
contribute
understanding
SARS-CoV-2,
which
could
design
future
strategies.
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 15, 2024
Abstract
Background
Hyperinflammation,
hypercoagulation
and
endothelial
injury
are
major
findings
in
acute
post-COVID-19.
The
SARS-CoV-2
S
protein
has
been
detected
as
an
isolated
element
human
tissues
reservoirs
is
the
main
product
of
mRNA
COVID-19
vaccines.
We
investigated
whether
alone
triggers
pro-inflammatory
pro-coagulant
responses
primary
cultures
two
cell
types
deeply
affected
by
SARS-CoV-2,
such
monocytes
cells.
Methods
In
umbilical
vein
cells
(HUVEC)
monocytes,
components
NF-κB
NLRP3
inflammasome
system,
well
coagulation
regulators,
were
assessed
qRT-PCR,
Western
blot,
flow
cytometry,
or
indirect
immunofluorescence.
Results
activated
NF-κB,
promoted
cytokines
release,
triggered
priming
activation
system
resulting
mature
IL-1β
formation
both
types.
This
was
paralleled
enhanced
production
factors
von
Willebrand
factor
(vWF),
VIII
tissue
factor,
that
mediated,
at
least
part,
IL-1β.
Additionally,
failed
to
enhance
ADAMTS-13
levels
counteract
activity
vWF
multimers.
Monocytes
HUVEC
barely
expressed
angiotensin-converting
enzyme-2.
Pharmacological
approaches
gene
silencing
showed
TLR4
receptors
mediated
effects
but
not
HUVEC.
Conclusion
behaves
a
stimulus
Interfering
with
signaling
pathways
evoked
may
help
preventing
immune
vascular
complications
driven
viral
element.
Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 29, 2022
Recognition
of
viral
infection
by
pattern
recognition
receptors
is
paramount
for
a
successful
immune
response
to
infection.
However,
an
unbalanced
proinflammatory
can
be
detrimental
the
host.
Recently,
multiple
studies
have
identified
that
SARS-CoV-2
spike
protein
activates
Toll-like
receptor
4
(TLR4),
resulting
in
induction
cytokine
expression.
Activation
TLR4
glycoproteins
has
also
been
observed
context
other
models,
including
respiratory
syncytial
virus
(RSV),
dengue
(DENV)
and
Ebola
(EBOV).
mechanisms
involved
virus-TLR4
interactions
remained
unclear.
Here,
we
review
act
as
pathogen-associated
molecular
patterns
induce
via
TLR4.
We
explore
current
understanding
underlying
how
are
recognized
discuss
contribution
activation
pathogenesis.
identify
contentious
findings
research
gaps
highlight
importance
glycoprotein-mediated
potential
therapeutic
approaches.
Frontiers in Virology,
Journal Year:
2022,
Volume and Issue:
2
Published: July 1, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
caused
a
global
pandemic
and
public
health
crisis
since
the
beginning
of
2020.
First
recognized
for
induction
disease,
virus
also
causes
asymptomatic
infections
or
with
mild
symptoms
that
can
resemble
common
colds.
To
provide
better
understanding
these
SARS-CoV-2
to
monitor
development
over
time,
we
performed
detailed
analysis
self-reported
positive
negative
individuals.
In
an
online-based
survey,
total
2117
individuals
provided
information
on
associated
infection,
1925
participants
had
tested
192
negative.
reported
most
frequently
during
early
phases
by
infected
were
tiredness,
headache,
impairment
smell
taste
dry
cough.
With
spread
alpha
delta
variants,
frequency
nose
such
as
blocked
runny
sneezing
increased
being
almost
60%
Interestingly,
omicron
variant
brought
sharp
decrease
in
incidence
impaired
sense
taste,
which
was
only
24%
this
phase
pandemic.
constellation
should
be
monitored
closely
months
ahead,
future
variants
are
likely
bring
about
more
changes.
International Journal of Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
136, P. 136 - 145
Published: Sept. 17, 2023
Vaccination
protects
against
severe
COVID-19
manifestations.
For
those
with
post-COVID-19
conditions
(PCC)
or
long
COVID,
the
impact
of
vaccination
on
evolution
symptoms,
immune
responses,
and
viral
persistence
is
unclear.In
this
prospective
observational
cohort
study,
we
evaluated
number
PCC
affected
organ
systems,
psychological
well-being
scores
before
after
patients
received
vaccination.
We
simultaneously
biomarkers
systemic
inflammation
levels
plasma
cytokines/chemokines.
measured
intracellular
SARS-CoV-2
antigens,
immunoreactivity
to
antigens
in
blood.COVID-19
was
associated
decreases
symptoms
(pre-vaccination:
6.56
±
3.1
vs
post-vaccination:
3.92
4.02;
P
<0.001)
systems
3.19
1.04
1.89
1.12;
<0.001),
increases
World
Health
Organization
(WHO)-5
Well-Being
Index
Scores
42.67
22.76
56.15
22.83;
<0.001).
Patients
also
had
significantly
decreased
several
pro-inflammatory
cytokines/chemokines
including
sCD40L,
GRO-⍺,
macrophage
inflammatory
protein
(MIP)-1⍺,
interleukin
(IL)-12p40,
G-colony
stimulating
factor
(CSF),
M-CSF,
IL-1β,
stem
cell
(SCF).
participants
presented
a
certain
level
toward
SARS-CoV-2,
that
boosted
S1
antigen
persisted
blood
participants,
mostly
non-classical
monocytes,
regardless
receiving
vaccination.Our
study
shows
higher
responses
brings
forward
possible
role
for
mitigating
by
decreasing
inflammation.
observed
products
independent
could
be
involved
perpetuating
through
monocytes.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(13), P. 2738 - 2738
Published: June 30, 2022
Black
rice
is
a
functional
food
that
high
in
anthocyanin
content,
primarily
C3G
and
P3G.
It
possesses
nutraceutical
properties
exhibit
range
of
beneficial
effects
on
human
health.
Currently,
the
spike
glycoprotein
S1
subunit
SARS-CoV-2
(SP)
has
been
reported
for
its
contribution
to
pathological
inflammatory
responses
targeting
lung
tissue
innate
immune
cells
during
COVID-19
infection
long-COVID
phenomenon.
Our
objectives
focused
health
benefits
P3G-rich
fraction
black
germ
bran
(BR
extract)
inhibition
induced
by
SP,
as
well
NF-kB
activation
NLRP3
inflammasome
pathway
an
vitro
model.
In
this
study,
BR
extract
was
identified
active
anthocyanins,
P3G,
using
HPLC
technique.
A549-lung
differentiated
THP-1
macrophages
were
treated
with
extract,
C3G,
or
P3G
prior
exposure
100
ng/mL
SP.
Their
anti-inflammatory
then
determined.
at
concentrations
12.5−100
μg/mL
exhibited
anti-inflammation
activity
both
A549
through
significant
suppression
NLRP3,
IL-1β,
IL-18
gene
expressions
IL-6,
cytokine
secretions
dose-dependent
manner
(p
<
0.05).
determined
cell
lines,
(at
1.25−10
μg/mL),
compatibly
responsible
SP-induced
protein
levels
With
regard
mechanism,
could
attenuate
inflammation
via
counteraction
downregulation
inflammasome-dependent
proteins
(NLRP3,
ASC,
capase-1).
Overall,
protective
anthocyanins
obtained
from
can
be
employed
potentially
preventive
strategies
use
pigmented
against
long-term
sequelae
infection.
Cureus,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 21, 2023
The
spike
protein
of
SARS-CoV-2
has
been
found
to
exhibit
pathogenic
characteristics
and
be
a
possible
cause
post-acute
sequelae
after
infection
or
COVID-19
vaccination.
vaccines
utilize
modified,
stabilized
prefusion
that
may
share
similar
toxic
effects
with
its
viral
counterpart.
aim
this
study
is
investigate
mechanisms
harm
biological
systems
from
vaccine-encoded
propose
mitigation
strategies.
We
searched
PubMed,
Google
Scholar,
‘grey
literature’
find
studies
(1)
investigated
the
on
systems,
(2)
helped
differentiate
between
vaccine-generated
proteins,
(3)
identified
detoxification
protocols
compounds
had
signals
benefit
acceptable
safety
profiles.
abundant
evidence
damage
in
cardiovascular,
hematological,
neurological,
respiratory,
gastrointestinal,
immunological
systems.
Viral
proteins
have
shown
play
direct
role
cardiovascular
thrombotic
injuries
both
Detection
for
at
least
6-15
months
vaccination
those
indicates
as
primary
contributing
factor
long
COVID.
rationalized
these
findings
give
support
potential
long-term
post-infection
and/or
vaccine-induced
complications.
base
protocol,
composed
oral
nattokinase,
bromelain,
curcumin.
This
approach
holds
immense
promise
clinical
care,
upon
which
additional
therapeutic
agents
are
applied
goal
aiding
resolution
Large-scale,
prospective,
randomized,
double-blind,
placebo-controlled
trials
warranted
order
determine
relative
risks
benefits
protocol.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(3), P. 754 - 754
Published: March 15, 2023
Critically
ill
COVID-19
patients
display
signs
of
generalized
hyperinflammation.
Macrophages
trigger
inflammation
to
eliminate
pathogens
and
repair
tissue,
but
this
process
can
also
lead
hyperinflammation
resulting
exaggerated
disease.
The
role
macrophages
in
dysregulated
during
SARS-CoV-2
infection
is
poorly
understood.
We
inoculated
treated
human
macrophage
cell
line
THP-1
with
purified,
glycosylated,
soluble
spike
protein
S1
subunit
(S1)
clarify
the
pro-inflammatory
responses.
Soluble
upregulated
TNF-α
CXCL10
mRNAs,
induced
secretion
from
macrophages.
While
did
not
support
productive
replication
or
viral
entry,
virus
exposure
resulted
upregulation
both
genes.
Our
study
shows
that
extracellular
a
key
component
inducing
responses
macrophages,
independent
replication.
Thus,
virus-
S1-activated
may
become
sources
mediators
contributing
patients.
iScience,
Journal Year:
2023,
Volume and Issue:
26(6), P. 106954 - 106954
Published: May 25, 2023
Neurological
complications
that
occur
in
SARS-CoV-2
infection,
such
as
olfactory
dysfunction,
brain
inflammation,
malaise,
and
depressive
symptoms,
are
thought
to
contribute
long
COVID.
However,
autopsies
of
patients
who
have
died
from
COVID-19,
there
is
normally
no
direct
evidence
central
nervous
system
damage
due
proliferation
SARS-CoV-2.
For
this
reason,
many
aspects
the
pathogenesis
mechanisms
symptoms
remain
unknown.
Expressing
S1
protein
nasal
cavity
mice
was
associated
with
increased
apoptosis
decreased
intracerebral
acetylcholine
production.
The
decrease
production
clinical
signs,
expression
cytokine
degrading
factor
ZFP36.
Administering
cholinesterase
inhibitor
donepezil
improved
malaise
signs.
These
findings
could
elucidation
neurological
COVID-19